Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma

被引:156
作者
Kontush, A [1 ]
Berndt, C [1 ]
Weber, W [1 ]
Akopyan, V [1 ]
Arlt, S [1 ]
Schippling, S [1 ]
Beisiegel, U [1 ]
机构
[1] Univ Krankenhaus Eppendorf, Med Kernklin & Poliklin, D-20246 Hamburg, Germany
关键词
amyloid-beta; antioxidant; lipoproteins; oxidation; cerebrospinal fluid; plasma; Alzheimer's disease; free radicals;
D O I
10.1016/S0891-5849(00)00458-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid-beta (A beta) peptide, a major constituent of senile plaques and a hallmark of Alzheimer's disease (AD), is normally secreted by neurons and can be found in low concentrations in cerebrospinal fluid (CSF) and plasma, where it is associated with lipoproteins. However, the physiological role of A beta secretion remains unknown. Here we show that at the concentrations measured in biological fluids (0.1-1.0 nM), A beta (1-40) strongly inhibits autooxidation of CSF lipoproteins and plasma low density lipoprotein (LDL). At higher concentrations of the peptide its antioxidant action was abolished. A beta (1-40) also inhibited copper-catalyzed LDL oxidation when added in molar excess of copper, but did not influence oxidation induced by an ate-initiator. Other A beta peptides also possessed antioxidant activity in the order A beta (1-40) > A beta (1-42) > A beta (25-35), whereas A beta (35-25), was inactive. These data suggest that A beta (1-40), may act as a physiological antioxidant in CSF and plasma lipoproteins, functioning by chelating transition metal ions. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 54 条
  • [31] LeBlanc AC, 1997, J NEUROCHEM, V68, P1183
  • [32] Copper, iron and zinc in Alzheimer's disease senile plaques
    Lovell, MA
    Robertson, JD
    Teesdale, WJ
    Campbell, JL
    Markesbery, WR
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (01) : 47 - 52
  • [33] Physiological levels of beta-amyloid peptide promote PC12 cell proliferation
    Luo, Y
    Sunderland, T
    Roth, GS
    Wolozin, B
    [J]. NEUROSCIENCE LETTERS, 1996, 217 (2-3) : 125 - 128
  • [34] Physiological levels of beta-amyloid peptide stimulate protein kinase C in PC12 cells
    Luo, Y
    Hawver, DB
    Iwasaki, K
    Sunderland, T
    Roth, GS
    Wolozin, B
    [J]. BRAIN RESEARCH, 1997, 769 (02) : 287 - 295
  • [35] ALUMINUM, IRON, AND ZINC IONS PROMOTE AGGREGATION OF PHYSIOLOGICAL CONCENTRATIONS OF BETA-AMYLOID PEPTIDE
    MANTYH, PW
    GHILARDI, JR
    ROGERS, S
    DEMASTER, E
    ALLEN, CJ
    STIMSON, ER
    MAGGIO, JE
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) : 1171 - 1174
  • [36] Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease
    Mark, RJ
    Blanc, EM
    Mattson, MP
    [J]. MOLECULAR NEUROBIOLOGY, 1996, 12 (03) : 211 - 224
  • [37] Oxidative stress hypothesis in Alzheimer's disease
    Markesbery, WR
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (01) : 134 - 147
  • [38] Distribution and fluidizing action of soluble and aggregated amyloid β-peptide in rat synaptic plasma membranes
    Mason, RP
    Jacob, RF
    Walter, MF
    Mason, PE
    Avdulov, NA
    Chochina, SV
    Igbavboa, U
    Wood, WG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18801 - 18807
  • [39] Montine TJ, 1997, AM J PATHOL, V151, P1571
  • [40] REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE
    MOTTER, R
    VIGOPELFREY, C
    KHOLODENKO, D
    BARBOUR, R
    JOHNSONWOOD, K
    GALASKO, D
    CHANG, L
    MILLER, B
    CLARK, C
    GREEN, R
    OLSON, D
    SOUTHWICK, P
    WOLFERT, R
    MUNROE, B
    LIEBERBURG, I
    SEUBERT, P
    SCHENK, D
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (04) : 643 - 648